SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-102314
Filing Date
2023-09-20
Accepted
2023-09-20 16:31:31
Documents
14
Period of Report
2023-09-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2326562d1_8k.htm   iXBRL 8-K 24760
2 EXHIBIT 99.1 tm2326562d1_ex99-1.htm EX-99.1 25135
6 GRAPHIC tm2326562d1_ex99-1img001.jpg GRAPHIC 3533
  Complete submission text file 0001104659-23-102314.txt   232719

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vcel-20230920.xsd EX-101.SCH 3003
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcel-20230920_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcel-20230920_pre.xml EX-101.PRE 22351
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2326562d1_8k_htm.xml XML 3191
Mailing Address 64 SIDNEY ST. CAMBRIDGE MA 02139
Business Address 64 SIDNEY ST. CAMBRIDGE MA 02139 7349305555
Vericel Corp (Filer) CIK: 0000887359 (see all company filings)

IRS No.: 943096597 | State of Incorp.: MI | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35280 | Film No.: 231266834
SIC: 2836 Biological Products, (No Diagnostic Substances)